Medico Remedies

₹18.98As of Sun 8 Nov 2026, 12:00 UTC

NSE:MEDICOHealthcare

Country India

PE (Fwd) 9.701

TSR 4Y CAGR (5.17%)

Div yield —

ROE —

Drug Manufacturers (Specialty & Generic)

Beta (5Y) 0.85

PE TTM 12.01

TSR TTM (62.38%)

Mkt cap ₹1.569B

ROIC —

SE Grade™

Value

Quality

Moat

—

1Y Price

Reference

₹21

9.92%

(62.18%)

Price above Reference Value

TTM

FYE 31 Mar INR

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

5Y

10Y

Peers

2.064

Revenue₹B

—

—

—

—

—

1.210

1.404

1.449

1.509

2.064

2.299

14.27%

14.27%

63

36.73

Revenue growth%

—

—

—

—

—

—

16.04

3.19

4.15

36.73

11.42

10.10

—

93

25.22

Gross margin%

—

—

—

—

—

26.67

24.74

23.24

26.96

25.22

25.16

25.22

25.22

27

6.75

Operating margin%

—

—

—

—

—

4.26

4.91

6.92

7.93

6.75

6.77

6.75

6.75

80

6.35

Net margin%

—

—

—

—

—

3.98

5.16

5.72

6.69

6.35

6.39

5.72

5.72

70

12.01

P/E ratio (avg)x

—

—

—

—

—

—

70.95

72.57

46.58

30.02

10.72

58.77

—

33

11.31

EV/EBITx

—

—

—

—

—

—

74.47

59.99

39.27

28.26

10.12

49.63

—

44

—

FCF yield (avg)%

—

—

—

—

—

—

—

—

—

—

—

—

—

76

—

FCF margin%

—

—

—

—

—

—

—

—

—

—

—

—

—

72

—

FCF / Net incomex

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

ROIC%

—

—

—

—

—

—

—

—

—

—

—

—

—

90

—

Return on equity%

—

—

—

—

—

—

—

—

—

—

—

—

—

92

—

Return on assets%

—

—

—

—

—

—

—

—

—

—

—

—

—

93

1.58

EPS₹

—

—

—

—

—

0.58

0.87

1.00

1.22

1.58

1.77

28.48%

28.48%

—

29.90

EPS growth%

—

—

—

—

—

—

50.49

14.49

21.74

29.90

12.07

25.82

—

—

—

Bookvalue per sh₹

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

FCF per share₹

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

Dividend per sh₹

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

Div yield (avg)%

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

Payout ratio%

—

—

—

—

—

—

—

—

—

—

—

—

—

—

83.01

Shares (diluted)M

—

—

—

—

—

82.98

82.98

82.98

82.98

83.01

◌83.01

0.01%

0.01%

68

(0.03)

Buyback yield%

—

—

—

—

—

—

—

—

—

(0.03)

◌—

—

—

68

—

D/E ratiox

—

—

—

—

—

—

—

—

—

—

—

—

—

48

1.575

Enterprise value₹B

—

—

—

—

—

—

5.138

6.017

4.702

3.937

1.575

(8.49%)

—

60

—

LT debt₹M

—

—

—

—

—

—

—

—

—

—

—

—

—

37

Peers (US$15.93M)

Cap (US$)

PE

Natural Capsules…

15.82M

—

Par Drugs and Chemical…

14.28M

10.32x

Bal Pharma Limited

13.93M

18.09x

Turk Ilac Ve Serum…

15.93M

—

Capital

TTM

5Y

10Y

Leveragex

—

—

—

EBIT/Intx

14.06

14.01

14.01

Own earn%

—

—

—

Sh yield%

(0.03)

—

—

Owners

Insiders/Inst%

70.87

1.20

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

5/5

Revenue growth years

4/4

EPS growth years

4/4

Dividend streakyrs

0

Op margin range%

4–8

$1 testx

—

Incr. ROIC%

—

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹2.064B

14.27%

1.00×

Cost of revenue

₹1.543B

14.84%

1.02×

Operating expenses

₹381.2M

8.88%

0.82×

Revenue by region

No breakdown available

Reinvestment returns

n/m

Trend

Reinvestment rate

n/m

-

Return on capital

n/m

-

Spread over hurdle

n/m

-